產(chǎn)品名稱 |
M5/49.4.1 |
商品貨號 |
B165056 |
Organism |
Rattus norvegicus (B cell); Mus musculus (myeloma), rat (B cell); mouse (myeloma) |
Tissue |
spleen |
Cell Type |
hybridoma: B lymphocyte |
Product Format |
frozen |
Morphology |
lymphoblast |
Culture Properties |
suspension |
Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Disease |
Lymphoma |
Storage Conditions |
liquid nitrogen vapor phase |
Derivation |
Spleen cells were fused with NS-1 myeloma cells. |
Genes Expressed |
immunoglobulin; monoclonal antibody; against Thy-1 |
Cellular Products |
immunoglobulin; monoclonal antibody; against Thy-1 |
Comments |
Animals were immunized with a secondary mixed lymphocyte culture (C57BL/6 mouse anti irradiated BN rat lymphoma). Spleen cells were fused with NS-1 myeloma cells. The antibody does not block CTL mediated cytotoxicity. |
Complete Growth Medium |
The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
Subculturing |
Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 X 105 viable cells/mL.
Interval: Maintain cell density between 5 X 104 and 5 X 105 viable cells/mL.
Medium Renewal: Every 2 to 3 days |
Cryopreservation |
Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase |
Culture Conditions |
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37°C |
Isotype |
rat IgG2a |
Name of Depositor |
TA Springer |
Deposited As |
rat (B cell); mouse (myeloma) |
References |
Davignon D, et al. Lymphocyte function-associated antigen 1 (LFA-1): a surface antigen distinct from Lyt-2,3 that participates in T lymphocyte-mediated killing. Proc. Natl. Acad. Sci. USA 78: 4535-4539, 1981. PubMed: 7027264
|